Sponsor or institution

Clinical trials and research at Chongqing Peg-Bio Biopharm Co., Ltd.

• 3Clinical trials
• 1Country

Newest trials

All recruiting trials (3)

• FT1 for adults with short bowel syndrome: a safe, quick-study test

  This trial tests FT1 vs placebo in adults with short bowel syndrome to see if FT1 is safe and helps with their condition.

  Recruiting Phase 2 Chongqing Peg-Bio Biopharm Co., Ltd. · Nanjing, Jiangsu · NCT07704047

• PA5 in adults with advanced solid tumors

  This trial tests PA5 as a single-drug treatment to see if it is safe and tolerable for adults with advanced solid tumors and to find an appropriate dose for future studies.

  Recruiting at 2 sites Phase 1 Chongqing Peg-Bio Biopharm Co., Ltd. · Fuzhou, Fujian and 1 other locations · NCT07702162

• PL54 injection safety in adults with PKU

  This study tests whether PL54 is safe and tolerable when given once or in multiple weekly shots to adults with phenylketonuria.

  Recruiting Phase 1 Chongqing Peg-Bio Biopharm Co., Ltd. · Hefei, Anhui · NCT07672756

Quick answers

How many clinical trials run by Chongqing Peg-Bio Biopharm Co., Ltd. are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →